Viewing Study NCT00062205


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-05-20 @ 3:25 PM
Study NCT ID: NCT00062205
Status: COMPLETED
Last Update Posted: 2010-02-09
First Post: 2003-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor
Sponsor: City of Hope Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CDR0000304551
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Warren Chow MD
Old Organization: City of Hope Medical Center

Collaborators

Collaborators

Name Class View
None NIH View